EIZO (6737) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Despite higher revenue and lower operating income, net income increased due to gains on the sale of policy-held shares. Revenue was ¥58.81B (+1.2% YoY), operating income was ¥1.32B (-39.1% YoY), ordinary income was ¥2.80B (-6.7% YoY), and net income was ¥2.84B (+42.6% YoY). The primary factors behind the decline in operating income were weak sales in the B&P market due to the sluggish European economy, as well as higher SG&A expenses associated with wage increases, new technology building costs, and the expansion of sales in India and the Middle East. The increase in net income was attributable to the recognition of a ¥1.33B gain on the sale of investment securities as extraordinary income.

Factors Affecting Earnings

【Revenue】Revenue was ¥58.81B, essentially flat at +1.2% YoY. The healthcare market grew to 105.8% of the previous-year level as endoscopy and diagnostic applications recovered in Europe, North America, and China. However, the core B&P market declined to 87.4% YoY due to the sluggish European economy, offsetting the overall result. Creative Work also remained weak at 95.0% YoY due to the delayed recovery in European demand.

【Profit and Loss】Operating income was ¥1.32B, down -39.1% YoY. The gross margin was 32.5%, deteriorating by -50bp YoY, while the SG&A ratio was 30.2%, worsening by +90bp YoY. Wage increases, new technology building expenses, and the expansion of overseas sales pushed up SG&A expenses. Ordinary income was ¥2.80B (-6.7% YoY), supported by non-operating income including ¥1.30B in dividend income and ¥0.08B in foreign exchange gains. Net income was ¥2.84B (+42.6% YoY) due to the one-time ¥1.33B gain on the sale of investment securities, widening the divergence from ordinary income. In conclusion, revenue increased while profit declined.

Segment Analysis

Although detailed disclosure of operating income and loss by segment is not available, the B&P market is positioned as the core business based on the revenue mix. B&P declined to 87.4% YoY due to the stagnation of the European economy and was the primary factor restraining company-wide earnings growth. Meanwhile, Healthcare performed well at 105.8% YoY, partially offsetting the decline in B&P. V&S was at 99.6% YoY due to the postponement of air traffic control projects, while Amusement remained broadly in line with the previous year at 102.4%.

Key Financial Metrics

Profitability: ROE was 2.8% (annualized), while the operating margin was 2.2% (down from approximately 3.7% in the previous year).
Financial soundness: The Equity Ratio was 76.0% (down from 78.8% in the previous year). Current assets of ¥78.44B compared with current liabilities of ¥21.74B resulted in a robust current ratio of approximately 360.7%.
Asset efficiency: Total assets expanded to ¥176.77B (from ¥157.76B in the previous year), with investment securities of ¥68.97B accounting for approximately 39% of total assets.

Cash Flow Analysis

Cash and deposits stood at ¥14.96B, a decrease of -¥6.10B (-29.0%) YoY. The increase in inventories, primarily raw materials (+¥4.13B), and capital expenditures associated with the construction of the new technology building were sources of cash outflow. Short-term borrowings increased by +75.4% YoY to ¥8.53B and were allocated to working capital and investment funding. Although individual disclosure of Operating CF, Investing CF, and Financing CF is not available, the decline in cash and increase in short-term borrowings suggest that investment activities and capital expenditures were the primary sources of funding demand. Cash generation is classified as requiring monitoring.

Quality of Earnings

Ordinary income of ¥2.80B and net income of ¥2.84B were at nearly the same level. However, this resulted from the one-time ¥1.33B gain on the sale of investment securities boosting net income and masking the weakness at the ordinary income level. Non-operating income was ¥1.70B, accounting for approximately 2.9% of revenue, with ¥1.30B in dividend income constituting the majority. Most of the ¥1.48B increase from operating income of ¥1.32B to ordinary income of ¥2.80B comprised dividend income and foreign exchange gains, which must be evaluated separately from the earnings power of the core business.

Earnings Forecast and Guidance

The full-year forecast was revised downward to revenue of ¥79.00B (-1.9% YoY), operating income of ¥1.40B (-62.2% YoY), and ordinary income of ¥2.90B (-36.3% YoY). The Q3 cumulative revenue progress rate was 74.4% (¥58.81B/¥79.00B), while the operating income progress rate was 94.3% (¥1.32B/¥1.40B), with operating income significantly exceeding the standard progress rate of 75%. This is because one-time losses are scheduled to be recorded in Q4, including an approximately ¥0.40B inventory valuation loss on legacy B&P products, an approximately ¥0.20B loss on the disposal of fixed assets, and an approximately ¥0.15B impairment loss. Accordingly, full-year operating income is expected to be substantially compressed in Q4.

Shareholder Returns

The dividend consists of ¥55 for the interim dividend and ¥52.5 for the year-end dividend, equivalent to ¥157.5 annually. The Payout Ratio against net income based on 40,872 thousand shares is estimated at approximately 234.6%, a high level. The Company has indicated a policy of smoothing the annual dividend to ¥55 in the next fiscal year, intending to return from the temporarily high Payout Ratio dependent on gains on the sale of investment securities. No share buybacks have been confirmed, and shareholder returns are evaluated solely based on the Payout Ratio.

Catalysts

【Short term】In Q4, the Company is scheduled to record an approximately ¥0.40B inventory valuation loss on legacy B&P products, an approximately ¥0.20B loss on the disposal of fixed assets, and an approximately ¥0.15B impairment loss at a European sales subsidiary, which are expected to weigh on full-year operating income.

【Long term】Future business developments include the launch of the AI edge computer “mitococa Edge V3” in April 2026, the introduction of new 4K monitors for healthcare applications, and the expansion of sales activities in the Indian and Middle Eastern markets.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the operating margin and net profit margin are below the industry median, indicating that profitability is relatively weak within the industry.

Growth and Capital Efficiency

The revenue growth rate also falls below the industry median, indicating relatively modest top-line growth.

※Source: Compiled by the Company

Risk Factors

1. European economic stagnation risk: The B&P market and Creative Work have been affected by weak European demand, declining to 87.4% and 95.0% YoY, respectively. An approximately ¥0.40B inventory valuation loss on legacy products is expected to be recorded in Q4.

2. Risk of fluctuations in the value of investment securities: Investment securities amounted to ¥68.97B, accounting for approximately 39% of total assets, while valuation differences on securities increased by ¥12.97B. This structure means that stock market fluctuations have a significant impact on net assets and comprehensive income.

3. Dependence on short-term funding: Short-term borrowings increased by +75.4% YoY to ¥8.53B, resulting in a high proportion of short-term debt within interest-bearing liabilities. Liquidity is covered in comparison with cash of ¥14.96B, but changes in refinancing conditions require attention.

Key Earnings Takeaways

1. The operating margin fell significantly from the previous year to 2.2%, with operating leverage turning negative due to both gross margin deterioration and higher SG&A expenses. One-time losses are also scheduled to be recorded in Q4, and the full-year operating income forecast has been revised downward.

2. The increase in net income was attributable to the one-time gain on the sale of investment securities, while ordinary income declined -6.7% YoY, indicating weakening earnings power in the core business. The divergence between ordinary income and net income is an important consideration when evaluating earnings quality.

3. The Payout Ratio is high at approximately 234.6%, but the Company has indicated a policy of smoothing the dividend to ¥55 in the next fiscal year. A return to distributions commensurate with earnings levels can be observed as a structural change.

Theoretical Share Price (For Reference)

Sensitivity: ¥2,608–¥2,751 at ±1% for the cost of equity, and ¥2,657–¥2,692 at ±0.1 for ω.

Notes:

• To exclude the impact of one-time gains and losses, normalized EPS calculated from ordinary income and other measures is used (the Company’s forecast EPS is ¥78.9).
• Because net income progress against the full-year forecast is 89%, exceeding the standard 75%, forecast EPS is adjusted upward within a maximum range of +10% (because companies ahead of their progress tend to outperform their forecasts; adjustments may be excessive for businesses with strong seasonality).
• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).

(Model: Residual Income Model (Ohlson type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional advisor as necessary.

---End of Report---